Eight Sleep enters a new growth phase as a predictive artificial intelligence (AI) health platform following a $1.5 billion valuation milestone.

Eight Sleep announces a strategic funding round led by Tether Investments on March 5, 2026, to transition from sleep optimization to a predictive health platform. The New York-based company currently operates in 34 countries and recently achieved free cash flow positivity while launching three new products.

The company is developing a predictive AI agent trained on over one billion hours of sleep data to anticipate and prevent sleep disruptions. This expansion includes seeking Food and Drug Administration (FDA) filings for sleep apnea detection to transform the hardware into a regulated medical device.

“We believe advanced personalized AI is the perfect pathway to understand and expand human potential,” said Paolo Ardoino, CEO of Tether. “Eight Sleep has the potential to define the future of health tech by building intelligence that learns, scales, and evolves directly with humankind, turning advanced AI into practical, everyday insights and enhancements about core human biology.”

🧭 FAQs

• What is the current market valuation for Eight Sleep? The company is now valued at $1.5 billion following its latest strategic investment.

• Which company led the recent funding round for Eight Sleep? Tether Investments led the round to fuel the company’s expansion into predictive AI.

• In how many countries are Eight Sleep products available? Consumers can currently purchase the sleep technology in 34 countries globally.

• Is Eight Sleep seeking regulatory approval in the United States? The company is advancing FDA filings for sleep apnea detection and mitigation.

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。